The OIG is reviewing who pays for drugs during Part A stays. See your exposure in 48 hours →

Family-supplied medications during a Part A SNF stay

Why family-supplied medications during a Part A SNF stay create cost and compliance risk, what CMS and the OIG have said, and a safer admissions process.

Get a free 48-hour audit Estimate your savings

Family-supplied medications during a Part A SNF stay are a compliance risk because the facility, not the resident or family, is financially responsible for the drugs it furnishes during a covered stay. CMS has said the facility's provider agreement precludes asking residents to supply their own medications to lower the facility's cost, and the OIG is now examining why some facilities obtained drugs from residents or families. When a family's Part D plan pays for a drug used during a Part A stay, that payment is likely improper.

What counts as a family-supplied medication?

A family-supplied medication is any drug administered in the facility that the facility did not obtain and pay for. It may come from the resident's own retail pharmacy, a mail-order or specialty pharmacy using the resident's Part D plan, or a supply the family brought from home or from the hospital.

The term matters only during a covered Part A day. Outside a Part A stay, a long-stay resident's drugs are usually paid by Part D, Medicaid or the resident, and the facility's own policies govern how outside supplies are handled.

Why is it a problem during a Part A stay?

Three rules point the same way.

First, 42 CFR 409.25 says Medicare pays for drugs as SNF care only if they represent a cost to the facility, are ordinarily furnished to inpatients, and are furnished for use in the facility.

Second, the Medicare Benefit Policy Manual, Chapter 8, §50.5 says a facility assures drug availability only if it assumes financial responsibility, meaning the supplier looks to the facility, not the patient, for payment.

Third, CMS addressed the practice directly. Responding to a comment in the FY 2018 SNF PPS final rule (82 FR 36548), it said that medications needed during a covered stay, with limited exceptions such as certain chemotherapy drugs, are included in the per diem. It said the provider agreement requires the SNF to accept that payment as payment in full, citing 42 CFR 489.21. It also noted that even if a SNF fails to furnish or arrange a service, the beneficiary is not to bear the financial liability. CMS repeated the point in the FY 2019 rule.

Part D does not fill the gap. Under 42 CFR 423.100, a drug is not a Part D drug if payment is available under Part A.

What could your building recover?

Two numbers, instant estimate. No email needed.

Estimated recoverable per year$0
See your full estimate Planning estimate for one building at 85% occupancy. How it works

What did the OIG find about family-supplied drugs?

The OIG's 2024 audit, A-09-21-03008, reviewed Part D payments for drugs dispensed during Part A stays from 2018 through 2020. The full report found:

  • Drugs dispensed by specialty pharmacies were primarily provided to SNFs by enrollees or their families.
  • For 34 of the 36 specialty items where records confirmed administration, the drug came from the enrollee or family.
  • In one example, a facility accepted a hospital referral only after the family agreed to supply a lung cancer drug. Part D paid $15,494 for one 30-tablet fill. The facility said it did not know the family was using Part D.
  • Enrollees paid an estimated $21 million out of pocket for drugs for which payment was available under the Part A SNF benefit.

The OIG then opened Work Plan project OAS-25-09-057. Where enrollees or families supplied drugs that Part D paid for, it will examine why the SNFs obtained the drugs from them.

Which situations carry the most risk?

SituationWho likely paidRisk to the facilityBetter practice
Admission accepted on condition the family supplies a high-cost drugThe resident's Part D plan and the residentHighest; this is the OIG's examplePrice the drug before admission; supply it through your pharmacy
Specialty pharmacy keeps shipping to the resident's home or the facilityPart DImproper Part D claims during the stayAsk the specialty pharmacy to stop Part D fills on admission
Family brings remaining home supply "to save waste"Already paid by Part D or the residentFacility used a drug it did not pay forFollow policy; document source; discuss with counsel and consultant pharmacist
Hospital sends a few doses with the residentThe hospitalLow, if brief and documentedNote quantity; bridge to your pharmacy supply
Drug on the consolidated billing exclusion listPart B, billed by the supplierNot a facility drug costConfirm the code and use on the current exclusion file

The last row is not a family-supplied problem at all. Some drugs, such as listed chemotherapy, are billed outside the Part A rate. Our guide to SNF consolidated billing exclusions explains how to check.

Can a resident ever use their own medication in a SNF?

Clinical and payment rules are different questions.

On the clinical side, many facilities have policies for medications brought from home. These typically cover identification, labeling, storage and pharmacist review. Requirements vary by state pharmacy and nursing home rules and by facility policy, so there is no single national answer. The federal pharmacy services rule at 42 CFR 483.45 requires the facility to provide drugs to its residents, or obtain them under an agreement, and to have procedures for acquiring, receiving and administering them.

On the payment side, the rules above are stricter. During a covered Part A day, the drug is part of the facility's bundled payment. If a facility uses a resident's own supply for any reason, how it documents that, and whether and how it accounts for the cost, are questions for counsel and the consultant pharmacist. We do not give legal advice on specific cases.

How should admissions handle a high-cost drug referral?

  1. Get the full medication list before accepting. Include specialty and mail-order drugs, not just the hospital discharge list.
  2. Price each high-cost drug with your pharmacy. Ask for the daily cost and any therapeutic alternatives your prescriber and consultant pharmacist could consider.
  3. Check the exclusion list. Some chemotherapy and ESRD-related drugs are billed outside your rate.
  4. Check the payer. For a Medicare Advantage resident, read the contract for drug carve-outs. See Medicare Advantage drug carve-outs.
  5. Make the decision in writing. Admission decisions carry their own regulatory considerations. Involve your administrator and, where needed, counsel.
  6. If you admit, supply the drug. Through your contracted pharmacy, billed to the facility for Part A days.
  7. Notify outside pharmacies. Ask any specialty or retail pharmacy filling the resident's drugs to stop Part D fills for the Part A period.
  8. Audit the MAR against invoices. Each administered drug on a Part A day should trace to a facility cost.

Free · 48 hours · no integration

Get a free 48-hour pharmacy audit

  • Send three files: invoices, census, contract
  • See overbilling and Part A exposure, line by line
  • BAA signed before any data moves

Why does this matter for the bottom line?

The figures below are an illustrative example, not drawn from any client.

A 110-bed facility admits eight residents a year on specialty drugs that cost $300 to $900 a day. Supplying them properly for an average 20-day stay could cost roughly $48,000 to $144,000 a year. That is real money, which is why planning matters. Our guide to high-cost drugs during a Part A stay covers pricing, exclusions and the PDPM payment side. The alternative, letting families supply the drugs, moves the cost to Part D and the resident and creates exactly the exposure the OIG is reviewing.

This is sharpest for an independent nursing home, where one expensive admission can move a month's margin.

Free report · New York editionThe Part A Pharmacy Report 202620 pages built from public CMS data: Part A days, drug cost estimates, the 20-point invoice checklist.Get the report

This article is general information, not legal or clinical advice. Policies on medications from home vary by state and facility. Facilities make their own admission, clinical and compliance decisions.

Frequently asked questions

Can a nursing home ask a family to bring in medications during a Medicare Part A stay?

CMS has said the provider agreement's payment-in-full terms preclude residents being asked to supply their own medications to lower the nursing home's cost during a covered stay. The OIG is reviewing why some facilities obtained drugs from residents or families. Talk to counsel before adopting any practice that relies on outside supplies.

Who pays for a resident's drugs during a Part A SNF stay?

The facility, out of its Medicare per diem, for drugs it ordinarily furnishes. Exceptions include drugs on the consolidated billing exclusion list, which are billed separately, and a limited take-home supply at discharge.

What if a family's Part D plan already paid for a drug used during the stay?

That Part D payment may be improper, because Part D does not cover drugs for which Part A payment is available. Document what happened and get advice from counsel on next steps.

Does this apply to Medicare Advantage residents?

The facility's contract with the plan governs drug payment for MA residents, and terms vary by plan. The same principle generally holds: drugs inside the contracted per diem are the facility's cost.

Get the 48-hour first look

Send three months of pharmacy invoices, your census and your pharmacy services agreement. Within 48 hours we flag Part A resident-days with no facility drug cost, a common sign of outside supply, and show the exposure. Request the free 48-hour audit or estimate your numbers with the savings calculator.